111 Capital Makes New Investment in Colgate-Palmolive (NYSE:CL)

111 Capital bought a new position in shares of Colgate-Palmolive (NYSE:CL - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 4,142 shares of the company's stock, valued at approximately $377,000.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of CL. Brighton Jones LLC lifted its stake in Colgate-Palmolive by 4.4% in the 4th quarter. Brighton Jones LLC now owns 10,578 shares of the company's stock worth $962,000 after purchasing an additional 450 shares in the last quarter. Blue Trust Inc. lifted its position in Colgate-Palmolive by 50.6% during the fourth quarter. Blue Trust Inc. now owns 7,928 shares of the company's stock worth $721,000 after buying an additional 2,665 shares in the last quarter. Union Bancaire Privee UBP SA acquired a new position in Colgate-Palmolive during the fourth quarter worth $32,000. Mount Yale Investment Advisors LLC increased its stake in shares of Colgate-Palmolive by 5.5% in the 4th quarter. Mount Yale Investment Advisors LLC now owns 3,299 shares of the company's stock worth $300,000 after acquiring an additional 173 shares during the last quarter. Finally, R Squared Ltd purchased a new position in shares of Colgate-Palmolive during the 4th quarter worth $165,000. 80.41% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of brokerages have commented on CL. Morgan Stanley reduced their target price on shares of Colgate-Palmolive from $111.00 to $104.00 and set an "overweight" rating on the stock in a research note on Monday, February 3rd. Barclays cut their price target on shares of Colgate-Palmolive from $89.00 to $86.00 and set an "equal weight" rating for the company in a report on Friday, April 11th. UBS Group upped their price objective on Colgate-Palmolive from $105.00 to $109.00 and gave the company a "buy" rating in a report on Thursday, April 17th. Wells Fargo & Company raised their target price on Colgate-Palmolive from $83.00 to $88.00 and gave the stock an "underweight" rating in a research note on Wednesday, April 2nd. Finally, Wall Street Zen downgraded shares of Colgate-Palmolive from a "buy" rating to a "hold" rating in a report on Wednesday, May 7th. One investment analyst has rated the stock with a sell rating, ten have given a hold rating and ten have assigned a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus price target of $102.12.

Colgate-Palmolive Stock Down 1.3%

Shares of CL stock traded down $1.25 during trading hours on Monday, reaching $91.69. 1,630,711 shares of the stock were exchanged, compared to its average volume of 4,686,563. Colgate-Palmolive has a 12-month low of $85.32 and a 12-month high of $109.30. The business's fifty day moving average is $92.02 and its two-hundred day moving average is $91.27. The company has a debt-to-equity ratio of 13.40, a current ratio of 0.92 and a quick ratio of 0.58. The firm has a market capitalization of $74.31 billion, a P/E ratio of 26.05, a P/E/G ratio of 4.20 and a beta of 0.39.

Colgate-Palmolive (NYSE:CL - Get Free Report) last released its quarterly earnings data on Friday, April 25th. The company reported $0.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.86 by $0.05. The business had revenue of $4.91 billion during the quarter, compared to analysts' expectations of $4.92 billion. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. The company's revenue for the quarter was down 3.0% on a year-over-year basis. During the same period in the previous year, the company earned $0.86 EPS. As a group, research analysts expect that Colgate-Palmolive will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, May 15th. Investors of record on Thursday, April 17th were given a $0.52 dividend. The ex-dividend date was Thursday, April 17th. This is a boost from Colgate-Palmolive's previous quarterly dividend of $0.50. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.27%. Colgate-Palmolive's dividend payout ratio is 58.76%.

Colgate-Palmolive announced that its Board of Directors has authorized a share buyback plan on Thursday, March 20th that permits the company to repurchase $5.00 billion in shares. This repurchase authorization permits the company to buy up to 6.8% of its stock through open market purchases. Stock repurchase plans are usually an indication that the company's management believes its shares are undervalued.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.